Micha Sam Raredon

Title: Micha Sam Raredon: Innovator in Lung Bioreactor Technology

Introduction

Micha Sam Raredon is an innovative inventor based in the United States. He has made significant contributions to the field of bioreactor technology, particularly in the development of systems for large-mammal lung tissue. His work aims to enhance the understanding and treatment of lung defects.

Latest Patents

Micha Sam Raredon holds a notable patent for a "Human And Large-Mammal Lung Bioreactor." This invention provides a bioreactor designed specifically for large-mammal lung tissue. The bioreactor is capable of hydraulic-driven negative-pressure and positive-pressure perfusion and ventilation. It delivers perfusion and ventilation at physiological rates, which are easily controllable. The design includes a support scaffold to accommodate the size of large-mammal lung tissue and a pleural sack that creates a small isolated fluid chamber around the engineered lung, minimizing the amount of culture media required. This invention also offers an in vitro model for examining the function of test agents and methods for alleviating lung defects in large mammals.

Career Highlights

Throughout his career, Micha Sam Raredon has worked with prestigious institutions, including Yale University and Raredon Resources, Inc. His experience in these organizations has contributed to his expertise in bioreactor technology and lung research.

Collaborations

Micha has collaborated with notable individuals in his field, including Tom Raredon and Laura E. Niklason. These partnerships have furthered his research and development efforts in lung bioreactor technology.

Conclusion

Micha Sam Raredon is a pioneering inventor whose work in lung bioreactor technology has the potential to advance medical research and treatment options for lung defects. His innovative approach and collaborations highlight the importance of interdisciplinary efforts in scientific advancements.